Boehringer Ingelheim, renowned as a global leader in animal health, commemorated the inauguration of a cutting-edge laboratory space at its St. Joseph, Missouri, location with a ribbon-cutting ceremony. This state-of-the-art facility, dedicated to research and development (R&D), particularly in the realm of biotherapeutics, heralds a new era of innovation in animal health products.
The establishment of this novel laboratory underscores Boehringer's unwavering commitment to pioneering advancements and maintaining the highest standards of excellence. Serving as a unique late-stage R&D laboratory, the first of its kind in the United States, it is meticulously designed to expedite the transition of products from development to manufacturing, thereby bolstering the company's capacity to cater to the needs of animals more effectively. The laboratory's adaptable layout and specialized equipment enable scientists to simulate operational processes, facilitating seamless transitions and optimizing operational efficiency.
Caroline Belmont, vice president of US Global Innovation at Boehringer Ingelheim, emphasized the pivotal role that this facility will play in propelling R&D efforts for future products, marking an exciting venture into new realms of innovation.
Situated in St. Joseph, Missouri, Boehringer's location holds strategic significance within the company's global network. Dedicated primarily to the development and production of animal health products for livestock and equines, this site underscores Boehringer's commitment to spearheading vaccine development and manufacturing within the industry, while also demonstrating its dedication to the local community.
Kim Young, president of KC Animal Health Corridor, lauded Boehringer Ingelheim's deep-rooted ties to the community and emphasized the facility's role in advancing research, development and manufacturing standards within the industry.
Caroline Belmont further emphasized the Midwest's pivotal role in Boehringer's global operations, attributing its significance to the region's rich agricultural heritage and extensive livestock farming. Positioned strategically within this community, Boehringer leverages local resources and expertise to drive advancements in the global animal health industry.
Boehringer Ingelheim's Animal Health business stands as a testament to the company's unwavering commitment to advancing animal well-being and driving innovation within the industry.
